Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

2018185 citationsJournal Articlegold Open Access

Authors

Annalisa Ruggeri · Sorbonne Université

Myriam Labopin · Inserm

Andrea Bacigalupo · Università Cattolica del Sacro Cuore

Boris V. Afanasyev

Jan J. Cornelissen · Erasmus MC Cancer Institute

Ahmet Elmaağaclı · Asklepios Klinik St. Georg

Maija Itälä‐Remes · Turku University Hospital

Abstract

For GVHD prophylaxis in MSD and UD HSCT, the addition of IS drugs to PT-Cy enhances its effect and reduces the risk of severe cGVHD, reducing mortality and improving survival.

Topics & Keywords

Hematopoietic Stem Cell Transplantation Acute Lymphoblastic Leukemia research Polyomavirus and related diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Hematology & Oncology

Volume 11, Issue 1, pp. 40-40

DOI: 10.1186/s13045-018-0586-4

Field-Weighted Citation Impact: 14.23